# Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma

> **NCT07169383** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Hina Malik** · enrollment: 160 (estimated)

## Conditions studied

- Melasma (Facial Melasma)

## Interventions

- **DRUG:** Melatonin tablet
- **DRUG:** Tranexamic Acid (TXA)

## Key facts

- **NCT ID:** NCT07169383
- **Lead sponsor:** Hina Malik
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-28
- **Primary completion:** 2025-12-28
- **Final completion:** 2025-12-28
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169383, "Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07169383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*